ReLive Mergers & Acquisitions

ReLive M&A Summary

ReLive has acquired 1 company, including 1 in the last 5 years.

The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

ReLive

ReLive Biotechnologies Ltd.

Room 401, Building 13, Building 16, Tree House No. 73, Tanmi Road, Jiangbei New District,
Nanjing,
China,

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2023-01-25 Co.Don · Life Science
Leipzig, Germany · www.codon.de

Co.Don is a biopharmaceutical company and manufacturer of cell transplants that focuses on the development, manufacture, and marketing of regenerative, joint-preserving cell therapies for the treatment of cartilage defects in joints with the body's own cells. It enables patients to lead active life through personalized cartilage cell therapy. In line with the corporate vision, it is actively working to make its EU-wide approved drug available in other European countries and thus more patients. Co.Don is headquartered in Germany (Leipzig, Teltow) and is also active in England, the Netherlands, Austria, and Switzerland.

- Add-on Acquisition

ReLive

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.